Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis.
PHYSIO_ENDOM
Effect of a Therapeutic-educational Physiotherapy Program on Pain and the Physical-functional Sphere in Women With Endometriosis and Its Impact on Quality of Life
1 other identifier
interventional
62
1 country
1
Brief Summary
This is a randomized clinical trial that will be carried out in women with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic-educational physiotherapy, which will combine therapeutic exercise with a pain education program, and the control group (CG) who will receive the pain education program. The participants will be evaluated at three moments: before starting the study (T1), after the 8-week treatment program (T2) and after another 8 weeks of follow-up in which they will be encouraged to continue with the treatment (T3). The initial assessment will include a medical and physiotherapy history, and at T1, T2 and T3 the following will be assessed: pain, abdominopelvic mobility, muscle status, functionality, sexual function, quality of life, stress and biomarkers of chronic inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 18, 2024
CompletedStudy Start
First participant enrolled
February 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2026
ExpectedJanuary 15, 2025
January 1, 2025
10 months
January 8, 2024
January 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Musculoskeletal pain - Pressure pain threshold
Pressure pain threshold measured in rectus abdominis and lumbar muscles
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Musculoskeletal pain - quantitative Sensory Testing
Quantitative sensory testing is a non-invasive technique used to assess and quantify sensory functions by determining sensation and pain thresholds using pressure.
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Musculoskeletal pain - pain drawing
Identification of pain areas through a pain map: this consists of a human figure on a two-dimensional plane on which the patient can express the representation of the pain areas on a schematic of the body surface.
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Musculoskeletal pain - Central Sensitisation Inventory
Central Sensitisation Inventory: is a self-report instrument that indirectly assesses somatic and emotional symptoms that have been found to be associated with Central Sensitisation.
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Secondary Outcomes (17)
Physical-Funcionality - Hand grip Strength
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Physical-Funcionality - functional performance
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Physical-Funcionality- Pelvic floor Dynamometry
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Physical-Funcionality - Body composition
3 assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
Physical-Funcionality - Motor control
assessent times: T1(pre-intervention), T2 (after 8 weeks intervention), T3 (after 16 weeks intervention)
- +12 more secondary outcomes
Study Arms (2)
Experimental
EXPERIMENTALThey will receive therapeutic-educational physiotherapy, which will combine therapeutic exercise with a pain education program,
Control
OTHERThey will receive the pain education program.
Interventions
The EG will carry out a total of 24 sessions, at a rate of 3 weekly sessions of 30 minutes each. The first session of each month will be in person and the rest will be done at home following video tutorials with an App (https://fisiotrack.com). The face-to-face sessions will be conducted by a women's health physiotherapist, and will consist on therapeutic exercises based on body awareness, motor control and respiratory awareness.They will also receive a pain education program with indications on pain education, as well as basic information and general advice on the positive effects of physical activity and a healthy lifestyle for endometriosis. In addition, biweekly supervision will be carried out via telephone or video conference by a specialized physiotherapist.
They will receive instructions on pain education, as well as basic information and general advice about the positive effects of physical activity and a healthy lifestyle for your endometriosis, in writing via email. In addition, they will receive biweekly supervision via telephone or video conference by a specialized physical therapist.
Eligibility Criteria
You may qualify if:
- Diagnosis of endometriosis made by imaging techniques (MRI or ultrasound) or by surgery.
- A period of 3 months or more since the last surgery if they have undergone surgery.
- Who are receiving hormone treatment and have their disease under control.
- Persistent pelvic pain for at least 3 months.
- With pain and hypertonus in the pelvic musculature, myofascial syndrome, vestibulodynia or pudendal neuropathy.
- Consent to participate in the study
- Capable of carrying out the follow-up of the study until the final visit.
- Who have audiovisual resources and the internet at their disposal.
You may not qualify if:
- Women in the menopausal phase
- Women undergoing fertility treatment or planning to undergo fertility treatment in the next 3 months.
- Pregnant women.
- Women undergoing physiotherapy treatment or who have undergone physiotherapy treatment in the last 3 months.
- Having suffered a fracture in the last 3 months in the lower limb that limits their functional capacity.
- Cognitive illness that prevents correct comprehension of the exercises.
- Musculoskeletal pathology or neuropathy in acute phase.
- Having suffered or suffering from a neoplastic disease.
- Untreated endometriosis
- Acquired genital abnormalities of the pelvis or pelvic floor.
- Women in a situation of litigation or economic compensation, or pending the granting of a degree of disability.
- Severe mental illness (schizophrenia, borderline personality disorder, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Valencialead
- Hospital Universitario La Fecollaborator
- Instituto de Investigacion Sanitaria La Fecollaborator
Study Sites (1)
Hospital Universitari i Politècnic La Fe,
Valencia, 46026, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
laura Fuentes Aparicio, PhD
University of Valencia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 18, 2024
Study Start
February 9, 2024
Primary Completion
December 14, 2024
Study Completion (Estimated)
December 22, 2026
Last Updated
January 15, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share